Pharmaco-Economic Evaluation of the Treatment used in Ophthalmological Practice
Keywords:
pharmacoeconomic evaluation, ophthalmology, medicines, relative risk, probabilities of events, cost-effectiveness analysis
Abstract
The most important among the clinical forms of glaucoma is primary open-angle glaucoma (POAG), which, according to various authors, occurs in 70%-92% of cases. Due to the high prevalence of POAG, late detection and serious prognosis for visual functions, this disease occupies a special place in clinical ophthalmology. The aim of the study is to conduct a pharmacoeconomic evaluation of Tafluprostvs Travoprost in patients with POAG. Materials and methods of research is pharmacoeconomic methods of analysis, in particular the calculation of the relative risk, the calculation of the probability of events, cost-effectiveness analysis. According to the calculated results of pharmacoeconomic analyzes, Tafluprost was relatively less expensive and more clinically effective than Travoprost in patients with primary open-angle glaucoma. Alternative treatment with Tafluprost contributes to savings in the overall treatment procedure. Therefore, we recommend adding Tafluprost to the list of essential medicines.
Downloads
How to Cite
Published
2022-04-08
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.